MFIC Corporation to Present at the First NanoEquity Europe Conference
Irwin Gruverman, P.E., MFIC's CEO, will familiarize attendees with MFIC's proprietary Microfluidizer(R) processor equipment line, offering laboratory through large volume production capability. MFIC's equipment has been employed to produce nanomaterials since 1985, including the processing of carbon nanotubes. The Company anticipates that it will enable the manufacture of nanomaterials and deployment of new applications of the rapidly expanding nanotechnology science. Many of the other foremost nanotechnology materials and tools companies will also be presenting, as well as leading venture investors in the nanotechnology space. Attending will be investors, analysts and institutional representatives, as well as potential users of MFIC's equipment.
Mr. Gruverman stated, "This is a great opportunity to introduce our technology and Microfluidizer processor equipment to European Nanotechnology developers, as well as to inform prospective investors of the MFIC advantage in enabling large scale manufacture of nanomaterials. MFIC's operating subsidiary, Microfluidics, is an equipment company which provides highly engineered, leading, high pressure processing equipment and solutions, primarily to pharmaceutical, biotechnology and coatings manufacturers. More than 3,000 systems have been placed worldwide over the past 15 years, with about 250 of these making commercial scale products. These products include many injectable drugs, fine coatings for automobile finishes, cosmetic formulations and inkjet ink. MFIC is leading a revolution in efficient continuous chemical reaction technology and continues to develop process equipment to produce the smallest, most uniform structures available. MFIC enables its customers to achieve manufacturing excellence and competitive advantage through unique superior processing capability."
Further details of the conference are available on the Deutsche Borse Website at: http://deutscheboerse.com/dbag/dispatch/en/listcontent/gdb_navigation/ listing/70_Events/10_Next_Events/Content_Files/ lc_event_nanotec_0605.htm (Due to the length of this URL, it may be necessary to copy and paste it into your Internet browser's URL address field. You may also need to remove an extra space in the URL if one exists.)
Forward Looking Statement
Management believes that this release contains forward-looking statements that are subject to certain risks and uncertainties including statements relating to the Company's plan to attain and/or increase operating profitability and/or to achieve net profitability. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results achieved by the Company to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that the actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including but not limited to the following risks and uncertainties: (i) whether the performance advantages of the Company's Microfluidizer(R) materials processing equipment or that a commercial market for the equipment will continue to develop, (ii) whether the performance advantages of the Company's MMR nanoparticle production systems will be realized commercially, (iii) whether the Company will be able to increase its market penetration and market share, (iv) whether the timing of orders will significantly affect quarterly revenues and resulting net income results for particular quarters which may cause increased volatility in the Company's stock price, and (v) whether the Company will have access to sufficient working capital through continued and improving cash flow from sales, proceeds from its private placement equity offering, and ongoing borrowing availability, the latter being subject to the Company's ability to comply with the covenants and terms of its loan agreement with its senior lender.
MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer(R) materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available.
The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. Microfluidizer processor systems are in use and afford significant competitive and economic advantages to MFIC equipment customers. Microfluidics maintains offices and applications laboratories in Newton, MA and Lampertheim, Germany. Further information about Microfluidics' equipment can be found at: www.microfluidicscorp.com